|
Providing the Pharmaceutical
Industries with Actionable Intelligence
MattsonJack's Oncology specialty group,
MattsonJack DaVinci,
offers clients quantitative and qualitative insights into
the complex oncology healthcare market. MattsonJack DaVinci
combines strategic and tactical marketing skills with extensive
technical and clinical expertise -- focusing on the rapidly
changing cancer care environment and related therapeutic areas.
MattsonJack DaVinci integrates primary research
conducted in the United States, Europe and Japan into business
and technological evaluations for single-client projects and
retainer-based consultation.
What MattsonJack DaVinci offers oncology
clients:
- more than 150 total years of healthcare
and cancer experience
- international and domestic expertise
- customized consulting approaches
- skillful primary research
- innovative analytical approaches
- unique modeling methodologies
- in-depth syndicated reports
- special pricing for small companies
MattsonJack DaVinci provides value to many
divisions and job levels within a pharmaceutical or biotechnology
company:
- product managers (global and domestic)
- business development executives
- business unit leaders
- sales and marketing managers
- reimbursement and managed care teams
Download
a summary of MattsonJack DaVinci's oncology's capabilities
(PDF)
Oncology Syndicated Reports and Databases
MattsonJack DaVinci has developed an extensive
oncology knowledge base, derived from current research efforts
- both multi-client and single-client, as well as past industry
and consulting experience. DaVinci provides oncology clients
with the following syndicated products:
CancerMPact®
Supportive
Care Perspectives
Oncology
Marketing Strategies™ U.S.
Oncology
Marketing Strategies™ Western Europe 2005
Future
Focus™: Myelodysplastic Syndromes (U.S.)
Future
Focus™: GI Stromal Tumor (U.S.)
These on-going, comprehensive studies provide
insights into current and future cancer dynamics in the United
States and international markets of key interest to market
researchers. Dedicated chapters provide invaluable evaluations
of patient populations, stakeholder trends, reimbursement
influencers, clinical management and emerging technologies,
as well as detailed market models. These reports are considered
the "gold standards" for oncology market assessments.
For more information on MattsonJack
DaVinci's oncology specialists,
phone (650) 212-7010 or e-mail info@mattsonjack.com |